Grotberg J B, Halpern D, Jensen O E
Biomedical Engineering Department, Northwestern University, Evanston 60208, USA.
J Appl Physiol (1985). 1995 Feb;78(2):750-6. doi: 10.1152/jappl.1995.78.2.750.
The spreading rate of an exogenous surfactant monolayer due to surface tension gradients is examined by using our previously reported theoretical analysis, with particular attention given to the effects of endogenous surfactant. It is found that the presence of an endogenous surfactant reduces the spreading rate of exogenous surfactant and that, in certain circumstances, the spreading may be halted. A recently published paper (F. F. Espinosa, A. H. Shapiro, J. J. Fredberg, and R. D. Kamm. J. Appl. Physiol. 75: 2028-2039, 1993) reaches the opposite conclusion about the effect of endogenous surfactant, i.e., that the presence of an endogenous surfactant increases the spreading rate of the exogenous surfactant. This communication discusses the relevant issues associated with these different results and what the implications may be for surfactant replacement therapy. It is found that the endogenous surfactant, which is ahead of the advancing exogenous surfactant front, undergoes a concentration increase due to surface area compression of the air-liquid interface. Hence the spreading exogenous surfactant can raise surfactant concentrations in regions distal to its own location, and this is a previously unrecognized potential therapeutic mechanism of instilled surfactants. After initial instillations of intratracheal boluses of exogenous surfactant, additional surfactant may better reach the desired target site if delivered by aerosol. Predictions of surfactant and piggy-backed drug-delivery times through the lung are also discussed.
利用我们之前报道的理论分析方法,研究了外源性表面活性剂单层由于表面张力梯度而产生的扩散速率,特别关注了内源性表面活性剂的影响。研究发现,内源性表面活性剂的存在会降低外源性表面活性剂的扩散速率,并且在某些情况下,扩散可能会停止。最近发表的一篇论文(F.F.埃斯皮诺萨、A.H.夏皮罗、J.J.弗雷德伯格和R.D.卡姆。《应用生理学杂志》75: 2028 - 2039, 1993)对外源性表面活性剂的影响得出了相反的结论,即内源性表面活性剂的存在会增加外源性表面活性剂的扩散速率。本通讯讨论了与这些不同结果相关的问题以及对表面活性剂替代疗法的潜在影响。研究发现,在内源性表面活性剂位于外源性表面活性剂前沿之前的区域,由于气液界面的表面积压缩,内源性表面活性剂的浓度会增加。因此,正在扩散的外源性表面活性剂可以提高其自身位置远端区域的表面活性剂浓度,这是一种以前未被认识到的注入表面活性剂的潜在治疗机制。在外源性表面活性剂气管内推注初始给药后,如果通过气雾剂给药,额外的表面活性剂可能会更好地到达期望的靶位点。还讨论了表面活性剂和搭载药物在肺部的输送时间预测。